nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—Alkylating Activity—Mechlorethamine—lymphatic system cancer	0.486	0.591	CiPCiCtD
Procarbazine—Alkylating Activity—Carmustine—lymphatic system cancer	0.337	0.409	CiPCiCtD
Procarbazine—CYP1B1—Mitoxantrone—lymphatic system cancer	0.106	1	CbGbCtD
Procarbazine—Infection—Fludarabine—lymphatic system cancer	0.000143	0.00198	CcSEcCtD
Procarbazine—Decreased appetite—Teniposide—lymphatic system cancer	0.000142	0.00197	CcSEcCtD
Procarbazine—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000142	0.00196	CcSEcCtD
Procarbazine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000141	0.00196	CcSEcCtD
Procarbazine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000141	0.00196	CcSEcCtD
Procarbazine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000141	0.00195	CcSEcCtD
Procarbazine—Stomatitis—Carmustine—lymphatic system cancer	0.000141	0.00195	CcSEcCtD
Procarbazine—Rash—Mechlorethamine—lymphatic system cancer	0.00014	0.00194	CcSEcCtD
Procarbazine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00014	0.00194	CcSEcCtD
Procarbazine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000139	0.00193	CcSEcCtD
Procarbazine—Pneumonia—Vincristine—lymphatic system cancer	0.000139	0.00192	CcSEcCtD
Procarbazine—Flushing—Bleomycin—lymphatic system cancer	0.000138	0.00191	CcSEcCtD
Procarbazine—Anorexia—Fludarabine—lymphatic system cancer	0.000137	0.0019	CcSEcCtD
Procarbazine—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000135	0.00187	CcSEcCtD
Procarbazine—Pneumonia—Mitoxantrone—lymphatic system cancer	0.000135	0.00187	CcSEcCtD
Procarbazine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000135	0.00187	CcSEcCtD
Procarbazine—Stomatitis—Vincristine—lymphatic system cancer	0.000134	0.00186	CcSEcCtD
Procarbazine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000134	0.00186	CcSEcCtD
Procarbazine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000134	0.00186	CcSEcCtD
Procarbazine—Chills—Bleomycin—lymphatic system cancer	0.000133	0.00185	CcSEcCtD
Procarbazine—Sweating—Vincristine—lymphatic system cancer	0.000132	0.00183	CcSEcCtD
Procarbazine—Nausea—Mechlorethamine—lymphatic system cancer	0.000132	0.00183	CcSEcCtD
Procarbazine—Alopecia—Bleomycin—lymphatic system cancer	0.000131	0.00182	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000131	0.00182	CcSEcCtD
Procarbazine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000131	0.00182	CcSEcCtD
Procarbazine—Jaundice—Mitoxantrone—lymphatic system cancer	0.000131	0.00182	CcSEcCtD
Procarbazine—Haemoglobin—Carmustine—lymphatic system cancer	0.00013	0.00181	CcSEcCtD
Procarbazine—Urticaria—Teniposide—lymphatic system cancer	0.00013	0.0018	CcSEcCtD
Procarbazine—Haemorrhage—Carmustine—lymphatic system cancer	0.00013	0.0018	CcSEcCtD
Procarbazine—Body temperature increased—Teniposide—lymphatic system cancer	0.00013	0.0018	CcSEcCtD
Procarbazine—Abdominal pain—Teniposide—lymphatic system cancer	0.00013	0.0018	CcSEcCtD
Procarbazine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000129	0.00179	CcSEcCtD
Procarbazine—Hallucination—Carmustine—lymphatic system cancer	0.000129	0.00179	CcSEcCtD
Procarbazine—Sweating—Mitoxantrone—lymphatic system cancer	0.000129	0.00179	CcSEcCtD
Procarbazine—Haematuria—Mitoxantrone—lymphatic system cancer	0.000128	0.00178	CcSEcCtD
Procarbazine—Dysarthria—Methotrexate—lymphatic system cancer	0.000127	0.00175	CcSEcCtD
Procarbazine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000125	0.00174	CcSEcCtD
Procarbazine—Fatigue—Fludarabine—lymphatic system cancer	0.000124	0.00172	CcSEcCtD
Procarbazine—Hallucination—Vincristine—lymphatic system cancer	0.000123	0.00171	CcSEcCtD
Procarbazine—Pain—Fludarabine—lymphatic system cancer	0.000123	0.00171	CcSEcCtD
Procarbazine—Constipation—Fludarabine—lymphatic system cancer	0.000123	0.00171	CcSEcCtD
Procarbazine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000121	0.00168	CcSEcCtD
Procarbazine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000121	0.00167	CcSEcCtD
Procarbazine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000121	0.00167	CcSEcCtD
Procarbazine—Flushing—Carmustine—lymphatic system cancer	0.00012	0.00167	CcSEcCtD
Procarbazine—Anaemia—Bleomycin—lymphatic system cancer	0.00012	0.00166	CcSEcCtD
Procarbazine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000119	0.00164	CcSEcCtD
Procarbazine—Asthenia—Teniposide—lymphatic system cancer	0.000118	0.00163	CcSEcCtD
Procarbazine—Melaena—Methotrexate—lymphatic system cancer	0.000117	0.00162	CcSEcCtD
Procarbazine—Pruritus—Teniposide—lymphatic system cancer	0.000116	0.00161	CcSEcCtD
Procarbazine—Arrhythmia—Carmustine—lymphatic system cancer	0.000116	0.00161	CcSEcCtD
Procarbazine—Leukopenia—Bleomycin—lymphatic system cancer	0.000116	0.00161	CcSEcCtD
Procarbazine—Alopecia—Carmustine—lymphatic system cancer	0.000115	0.00159	CcSEcCtD
Procarbazine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000114	0.00158	CcSEcCtD
Procarbazine—Cough—Bleomycin—lymphatic system cancer	0.000113	0.00156	CcSEcCtD
Procarbazine—Diarrhoea—Teniposide—lymphatic system cancer	0.000112	0.00155	CcSEcCtD
Procarbazine—Myalgia—Bleomycin—lymphatic system cancer	0.00011	0.00153	CcSEcCtD
Procarbazine—Alopecia—Vincristine—lymphatic system cancer	0.000109	0.00152	CcSEcCtD
Procarbazine—Coma—Methotrexate—lymphatic system cancer	0.000109	0.00152	CcSEcCtD
Procarbazine—Chills—Mitoxantrone—lymphatic system cancer	0.000108	0.0015	CcSEcCtD
Procarbazine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000108	0.00149	CcSEcCtD
Procarbazine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000107	0.00148	CcSEcCtD
Procarbazine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000107	0.00148	CcSEcCtD
Procarbazine—Confusional state—Bleomycin—lymphatic system cancer	0.000106	0.00148	CcSEcCtD
Procarbazine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000106	0.00147	CcSEcCtD
Procarbazine—Tremor—Carmustine—lymphatic system cancer	0.000106	0.00147	CcSEcCtD
Procarbazine—Oedema—Bleomycin—lymphatic system cancer	0.000106	0.00146	CcSEcCtD
Procarbazine—Infection—Bleomycin—lymphatic system cancer	0.000105	0.00145	CcSEcCtD
Procarbazine—Anaemia—Carmustine—lymphatic system cancer	0.000104	0.00145	CcSEcCtD
Procarbazine—Vomiting—Teniposide—lymphatic system cancer	0.000104	0.00144	CcSEcCtD
Procarbazine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000103	0.00143	CcSEcCtD
Procarbazine—Asthenia—Fludarabine—lymphatic system cancer	0.000103	0.00143	CcSEcCtD
Procarbazine—Rash—Teniposide—lymphatic system cancer	0.000103	0.00143	CcSEcCtD
Procarbazine—Dermatitis—Teniposide—lymphatic system cancer	0.000103	0.00143	CcSEcCtD
Procarbazine—Headache—Teniposide—lymphatic system cancer	0.000103	0.00142	CcSEcCtD
Procarbazine—Pruritus—Fludarabine—lymphatic system cancer	0.000102	0.00141	CcSEcCtD
Procarbazine—Leukopenia—Carmustine—lymphatic system cancer	0.000101	0.0014	CcSEcCtD
Procarbazine—Anorexia—Bleomycin—lymphatic system cancer	0.000101	0.00139	CcSEcCtD
Procarbazine—Anaemia—Vincristine—lymphatic system cancer	9.97e-05	0.00138	CcSEcCtD
Procarbazine—Photosensitivity—Methotrexate—lymphatic system cancer	9.89e-05	0.00137	CcSEcCtD
Procarbazine—Hypotension—Bleomycin—lymphatic system cancer	9.87e-05	0.00137	CcSEcCtD
Procarbazine—Diarrhoea—Fludarabine—lymphatic system cancer	9.86e-05	0.00137	CcSEcCtD
Procarbazine—Convulsion—Carmustine—lymphatic system cancer	9.79e-05	0.00136	CcSEcCtD
Procarbazine—Hypertension—Carmustine—lymphatic system cancer	9.75e-05	0.00135	CcSEcCtD
Procarbazine—Nausea—Teniposide—lymphatic system cancer	9.73e-05	0.00135	CcSEcCtD
Procarbazine—Anaemia—Mitoxantrone—lymphatic system cancer	9.71e-05	0.00134	CcSEcCtD
Procarbazine—Leukopenia—Vincristine—lymphatic system cancer	9.65e-05	0.00134	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	9.62e-05	0.00133	CcSEcCtD
Procarbazine—Myalgia—Carmustine—lymphatic system cancer	9.62e-05	0.00133	CcSEcCtD
Procarbazine—Anxiety—Carmustine—lymphatic system cancer	9.58e-05	0.00133	CcSEcCtD
Procarbazine—Paraesthesia—Bleomycin—lymphatic system cancer	9.48e-05	0.00131	CcSEcCtD
Procarbazine—Leukopenia—Mitoxantrone—lymphatic system cancer	9.4e-05	0.0013	CcSEcCtD
Procarbazine—Convulsion—Vincristine—lymphatic system cancer	9.34e-05	0.00129	CcSEcCtD
Procarbazine—Hypertension—Vincristine—lymphatic system cancer	9.31e-05	0.00129	CcSEcCtD
Procarbazine—Confusional state—Carmustine—lymphatic system cancer	9.3e-05	0.00129	CcSEcCtD
Procarbazine—Oedema—Carmustine—lymphatic system cancer	9.22e-05	0.00128	CcSEcCtD
Procarbazine—Decreased appetite—Bleomycin—lymphatic system cancer	9.18e-05	0.00127	CcSEcCtD
Procarbazine—Myalgia—Vincristine—lymphatic system cancer	9.18e-05	0.00127	CcSEcCtD
Procarbazine—Cough—Mitoxantrone—lymphatic system cancer	9.16e-05	0.00127	CcSEcCtD
Procarbazine—Infection—Carmustine—lymphatic system cancer	9.16e-05	0.00127	CcSEcCtD
Procarbazine—Vomiting—Fludarabine—lymphatic system cancer	9.16e-05	0.00127	CcSEcCtD
Procarbazine—Convulsion—Mitoxantrone—lymphatic system cancer	9.1e-05	0.00126	CcSEcCtD
Procarbazine—Rash—Fludarabine—lymphatic system cancer	9.08e-05	0.00126	CcSEcCtD
Procarbazine—Dermatitis—Fludarabine—lymphatic system cancer	9.07e-05	0.00126	CcSEcCtD
Procarbazine—Hypertension—Mitoxantrone—lymphatic system cancer	9.07e-05	0.00126	CcSEcCtD
Procarbazine—Pain—Bleomycin—lymphatic system cancer	9.03e-05	0.00125	CcSEcCtD
Procarbazine—Thrombocytopenia—Carmustine—lymphatic system cancer	9.03e-05	0.00125	CcSEcCtD
Procarbazine—Headache—Fludarabine—lymphatic system cancer	9.02e-05	0.00125	CcSEcCtD
Procarbazine—Tachycardia—Carmustine—lymphatic system cancer	9e-05	0.00125	CcSEcCtD
Procarbazine—Myalgia—Mitoxantrone—lymphatic system cancer	8.94e-05	0.00124	CcSEcCtD
Procarbazine—Arthralgia—Mitoxantrone—lymphatic system cancer	8.94e-05	0.00124	CcSEcCtD
Procarbazine—Anxiety—Mitoxantrone—lymphatic system cancer	8.91e-05	0.00123	CcSEcCtD
Procarbazine—Lethargy—Methotrexate—lymphatic system cancer	8.87e-05	0.00123	CcSEcCtD
Procarbazine—Oedema—Vincristine—lymphatic system cancer	8.8e-05	0.00122	CcSEcCtD
Procarbazine—Anorexia—Carmustine—lymphatic system cancer	8.79e-05	0.00122	CcSEcCtD
Procarbazine—Infection—Vincristine—lymphatic system cancer	8.74e-05	0.00121	CcSEcCtD
Procarbazine—Feeling abnormal—Bleomycin—lymphatic system cancer	8.7e-05	0.00121	CcSEcCtD
Procarbazine—Confusional state—Mitoxantrone—lymphatic system cancer	8.64e-05	0.0012	CcSEcCtD
Procarbazine—Thrombocytopenia—Vincristine—lymphatic system cancer	8.62e-05	0.00119	CcSEcCtD
Procarbazine—Hypotension—Carmustine—lymphatic system cancer	8.61e-05	0.00119	CcSEcCtD
Procarbazine—Oedema—Mitoxantrone—lymphatic system cancer	8.57e-05	0.00119	CcSEcCtD
Procarbazine—Nausea—Fludarabine—lymphatic system cancer	8.56e-05	0.00119	CcSEcCtD
Procarbazine—Infection—Mitoxantrone—lymphatic system cancer	8.51e-05	0.00118	CcSEcCtD
Procarbazine—Hyperhidrosis—Vincristine—lymphatic system cancer	8.51e-05	0.00118	CcSEcCtD
Procarbazine—Shock—Mitoxantrone—lymphatic system cancer	8.43e-05	0.00117	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	8.4e-05	0.00116	CcSEcCtD
Procarbazine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	8.39e-05	0.00116	CcSEcCtD
Procarbazine—Urticaria—Bleomycin—lymphatic system cancer	8.39e-05	0.00116	CcSEcCtD
Procarbazine—Anorexia—Vincristine—lymphatic system cancer	8.39e-05	0.00116	CcSEcCtD
Procarbazine—Tachycardia—Mitoxantrone—lymphatic system cancer	8.36e-05	0.00116	CcSEcCtD
Procarbazine—Body temperature increased—Bleomycin—lymphatic system cancer	8.35e-05	0.00116	CcSEcCtD
Procarbazine—Insomnia—Carmustine—lymphatic system cancer	8.34e-05	0.00116	CcSEcCtD
Procarbazine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	8.29e-05	0.00115	CcSEcCtD
Procarbazine—Paraesthesia—Carmustine—lymphatic system cancer	8.28e-05	0.00115	CcSEcCtD
Procarbazine—Hypotension—Vincristine—lymphatic system cancer	8.22e-05	0.00114	CcSEcCtD
Procarbazine—Somnolence—Carmustine—lymphatic system cancer	8.2e-05	0.00114	CcSEcCtD
Procarbazine—Anorexia—Mitoxantrone—lymphatic system cancer	8.17e-05	0.00113	CcSEcCtD
Procarbazine—Ataxia—Methotrexate—lymphatic system cancer	8.17e-05	0.00113	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	8.02e-05	0.00111	CcSEcCtD
Procarbazine—Decreased appetite—Carmustine—lymphatic system cancer	8.01e-05	0.00111	CcSEcCtD
Procarbazine—Hypotension—Mitoxantrone—lymphatic system cancer	8.01e-05	0.00111	CcSEcCtD
Procarbazine—Insomnia—Vincristine—lymphatic system cancer	7.96e-05	0.0011	CcSEcCtD
Procarbazine—Paraesthesia—Vincristine—lymphatic system cancer	7.9e-05	0.00109	CcSEcCtD
Procarbazine—Pain—Carmustine—lymphatic system cancer	7.88e-05	0.00109	CcSEcCtD
Procarbazine—Constipation—Carmustine—lymphatic system cancer	7.88e-05	0.00109	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	7.82e-05	0.00108	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	7.81e-05	0.00108	CcSEcCtD
Procarbazine—Hypersensitivity—Bleomycin—lymphatic system cancer	7.78e-05	0.00108	CcSEcCtD
Procarbazine—Paraesthesia—Mitoxantrone—lymphatic system cancer	7.7e-05	0.00107	CcSEcCtD
Procarbazine—Decreased appetite—Vincristine—lymphatic system cancer	7.65e-05	0.00106	CcSEcCtD
Procarbazine—Somnolence—Mitoxantrone—lymphatic system cancer	7.62e-05	0.00106	CcSEcCtD
Procarbazine—Feeling abnormal—Carmustine—lymphatic system cancer	7.6e-05	0.00105	CcSEcCtD
Procarbazine—Fatigue—Vincristine—lymphatic system cancer	7.59e-05	0.00105	CcSEcCtD
Procarbazine—Asthenia—Bleomycin—lymphatic system cancer	7.58e-05	0.00105	CcSEcCtD
Procarbazine—Gastrointestinal pain—Carmustine—lymphatic system cancer	7.54e-05	0.00104	CcSEcCtD
Procarbazine—Constipation—Vincristine—lymphatic system cancer	7.53e-05	0.00104	CcSEcCtD
Procarbazine—Pain—Vincristine—lymphatic system cancer	7.53e-05	0.00104	CcSEcCtD
Procarbazine—Pruritus—Bleomycin—lymphatic system cancer	7.47e-05	0.00104	CcSEcCtD
Procarbazine—Decreased appetite—Mitoxantrone—lymphatic system cancer	7.45e-05	0.00103	CcSEcCtD
Procarbazine—Eosinophilia—Methotrexate—lymphatic system cancer	7.43e-05	0.00103	CcSEcCtD
Procarbazine—Fatigue—Mitoxantrone—lymphatic system cancer	7.39e-05	0.00102	CcSEcCtD
Procarbazine—Pancreatitis—Methotrexate—lymphatic system cancer	7.36e-05	0.00102	CcSEcCtD
Procarbazine—Pain—Mitoxantrone—lymphatic system cancer	7.33e-05	0.00102	CcSEcCtD
Procarbazine—Constipation—Mitoxantrone—lymphatic system cancer	7.33e-05	0.00102	CcSEcCtD
Procarbazine—Abdominal pain—Carmustine—lymphatic system cancer	7.29e-05	0.00101	CcSEcCtD
Procarbazine—Body temperature increased—Carmustine—lymphatic system cancer	7.29e-05	0.00101	CcSEcCtD
Procarbazine—Gastrointestinal pain—Vincristine—lymphatic system cancer	7.2e-05	0.000997	CcSEcCtD
Procarbazine—Pancytopenia—Methotrexate—lymphatic system cancer	7.13e-05	0.000988	CcSEcCtD
Procarbazine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	7.06e-05	0.000979	CcSEcCtD
Procarbazine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	7.01e-05	0.000971	CcSEcCtD
Procarbazine—Abdominal pain—Vincristine—lymphatic system cancer	6.96e-05	0.000964	CcSEcCtD
Procarbazine—Body temperature increased—Vincristine—lymphatic system cancer	6.96e-05	0.000964	CcSEcCtD
Procarbazine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	6.85e-05	0.00095	CcSEcCtD
Procarbazine—Urticaria—Mitoxantrone—lymphatic system cancer	6.81e-05	0.000943	CcSEcCtD
Procarbazine—Hypersensitivity—Carmustine—lymphatic system cancer	6.79e-05	0.000941	CcSEcCtD
Procarbazine—Abdominal pain—Mitoxantrone—lymphatic system cancer	6.77e-05	0.000939	CcSEcCtD
Procarbazine—Body temperature increased—Mitoxantrone—lymphatic system cancer	6.77e-05	0.000939	CcSEcCtD
Procarbazine—Pneumonia—Methotrexate—lymphatic system cancer	6.73e-05	0.000933	CcSEcCtD
Procarbazine—Vomiting—Bleomycin—lymphatic system cancer	6.71e-05	0.00093	CcSEcCtD
Procarbazine—Drowsiness—Methotrexate—lymphatic system cancer	6.69e-05	0.000928	CcSEcCtD
Procarbazine—Rash—Bleomycin—lymphatic system cancer	6.66e-05	0.000923	CcSEcCtD
Procarbazine—Dermatitis—Bleomycin—lymphatic system cancer	6.65e-05	0.000922	CcSEcCtD
Procarbazine—Asthenia—Carmustine—lymphatic system cancer	6.61e-05	0.000917	CcSEcCtD
Procarbazine—Stomatitis—Methotrexate—lymphatic system cancer	6.53e-05	0.000904	CcSEcCtD
Procarbazine—Hypersensitivity—Vincristine—lymphatic system cancer	6.48e-05	0.000898	CcSEcCtD
Procarbazine—Sweating—Methotrexate—lymphatic system cancer	6.42e-05	0.000889	CcSEcCtD
Procarbazine—Haematuria—Methotrexate—lymphatic system cancer	6.38e-05	0.000885	CcSEcCtD
Procarbazine—Epistaxis—Methotrexate—lymphatic system cancer	6.31e-05	0.000875	CcSEcCtD
Procarbazine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	6.31e-05	0.000875	CcSEcCtD
Procarbazine—Asthenia—Vincristine—lymphatic system cancer	6.31e-05	0.000875	CcSEcCtD
Procarbazine—Diarrhoea—Carmustine—lymphatic system cancer	6.31e-05	0.000874	CcSEcCtD
Procarbazine—Nausea—Bleomycin—lymphatic system cancer	6.27e-05	0.000869	CcSEcCtD
Procarbazine—Asthenia—Mitoxantrone—lymphatic system cancer	6.15e-05	0.000852	CcSEcCtD
Procarbazine—Dizziness—Carmustine—lymphatic system cancer	6.1e-05	0.000845	CcSEcCtD
Procarbazine—Haemoglobin—Methotrexate—lymphatic system cancer	6.04e-05	0.000837	CcSEcCtD
Procarbazine—Diarrhoea—Vincristine—lymphatic system cancer	6.02e-05	0.000834	CcSEcCtD
Procarbazine—Haemorrhage—Methotrexate—lymphatic system cancer	6.01e-05	0.000833	CcSEcCtD
Procarbazine—Diarrhoea—Mitoxantrone—lymphatic system cancer	5.86e-05	0.000813	CcSEcCtD
Procarbazine—Vomiting—Carmustine—lymphatic system cancer	5.86e-05	0.000812	CcSEcCtD
Procarbazine—Dizziness—Vincristine—lymphatic system cancer	5.82e-05	0.000806	CcSEcCtD
Procarbazine—Rash—Carmustine—lymphatic system cancer	5.81e-05	0.000805	CcSEcCtD
Procarbazine—Dermatitis—Carmustine—lymphatic system cancer	5.81e-05	0.000805	CcSEcCtD
Procarbazine—Headache—Carmustine—lymphatic system cancer	5.78e-05	0.0008	CcSEcCtD
Procarbazine—Vomiting—Vincristine—lymphatic system cancer	5.6e-05	0.000775	CcSEcCtD
Procarbazine—Rash—Vincristine—lymphatic system cancer	5.55e-05	0.000769	CcSEcCtD
Procarbazine—Dermatitis—Vincristine—lymphatic system cancer	5.54e-05	0.000768	CcSEcCtD
Procarbazine—Headache—Vincristine—lymphatic system cancer	5.51e-05	0.000764	CcSEcCtD
Procarbazine—Nausea—Carmustine—lymphatic system cancer	5.48e-05	0.000759	CcSEcCtD
Procarbazine—Vomiting—Mitoxantrone—lymphatic system cancer	5.45e-05	0.000755	CcSEcCtD
Procarbazine—Rash—Mitoxantrone—lymphatic system cancer	5.4e-05	0.000749	CcSEcCtD
Procarbazine—Dermatitis—Mitoxantrone—lymphatic system cancer	5.4e-05	0.000748	CcSEcCtD
Procarbazine—Chills—Methotrexate—lymphatic system cancer	5.39e-05	0.000747	CcSEcCtD
Procarbazine—Headache—Mitoxantrone—lymphatic system cancer	5.37e-05	0.000744	CcSEcCtD
Procarbazine—Alopecia—Methotrexate—lymphatic system cancer	5.31e-05	0.000736	CcSEcCtD
Procarbazine—Nausea—Vincristine—lymphatic system cancer	5.23e-05	0.000724	CcSEcCtD
Procarbazine—Nausea—Mitoxantrone—lymphatic system cancer	5.09e-05	0.000705	CcSEcCtD
Procarbazine—Anaemia—Methotrexate—lymphatic system cancer	4.84e-05	0.00067	CcSEcCtD
Procarbazine—Leukopenia—Methotrexate—lymphatic system cancer	4.68e-05	0.000649	CcSEcCtD
Procarbazine—Cough—Methotrexate—lymphatic system cancer	4.57e-05	0.000633	CcSEcCtD
Procarbazine—Convulsion—Methotrexate—lymphatic system cancer	4.53e-05	0.000628	CcSEcCtD
Procarbazine—Arthralgia—Methotrexate—lymphatic system cancer	4.45e-05	0.000617	CcSEcCtD
Procarbazine—Myalgia—Methotrexate—lymphatic system cancer	4.45e-05	0.000617	CcSEcCtD
Procarbazine—Confusional state—Methotrexate—lymphatic system cancer	4.31e-05	0.000597	CcSEcCtD
Procarbazine—Infection—Methotrexate—lymphatic system cancer	4.24e-05	0.000588	CcSEcCtD
Procarbazine—Thrombocytopenia—Methotrexate—lymphatic system cancer	4.18e-05	0.000579	CcSEcCtD
Procarbazine—Hyperhidrosis—Methotrexate—lymphatic system cancer	4.13e-05	0.000572	CcSEcCtD
Procarbazine—Anorexia—Methotrexate—lymphatic system cancer	4.07e-05	0.000564	CcSEcCtD
Procarbazine—Hypotension—Methotrexate—lymphatic system cancer	3.99e-05	0.000553	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	3.89e-05	0.000539	CcSEcCtD
Procarbazine—Insomnia—Methotrexate—lymphatic system cancer	3.86e-05	0.000535	CcSEcCtD
Procarbazine—Paraesthesia—Methotrexate—lymphatic system cancer	3.83e-05	0.000531	CcSEcCtD
Procarbazine—Somnolence—Methotrexate—lymphatic system cancer	3.8e-05	0.000526	CcSEcCtD
Procarbazine—Decreased appetite—Methotrexate—lymphatic system cancer	3.71e-05	0.000514	CcSEcCtD
Procarbazine—Fatigue—Methotrexate—lymphatic system cancer	3.68e-05	0.00051	CcSEcCtD
Procarbazine—Pain—Methotrexate—lymphatic system cancer	3.65e-05	0.000506	CcSEcCtD
Procarbazine—Feeling abnormal—Methotrexate—lymphatic system cancer	3.52e-05	0.000488	CcSEcCtD
Procarbazine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	3.49e-05	0.000484	CcSEcCtD
Procarbazine—Urticaria—Methotrexate—lymphatic system cancer	3.39e-05	0.00047	CcSEcCtD
Procarbazine—Abdominal pain—Methotrexate—lymphatic system cancer	3.38e-05	0.000468	CcSEcCtD
Procarbazine—Body temperature increased—Methotrexate—lymphatic system cancer	3.38e-05	0.000468	CcSEcCtD
Procarbazine—Hypersensitivity—Methotrexate—lymphatic system cancer	3.15e-05	0.000436	CcSEcCtD
Procarbazine—Asthenia—Methotrexate—lymphatic system cancer	3.06e-05	0.000425	CcSEcCtD
Procarbazine—Pruritus—Methotrexate—lymphatic system cancer	3.02e-05	0.000419	CcSEcCtD
Procarbazine—Diarrhoea—Methotrexate—lymphatic system cancer	2.92e-05	0.000405	CcSEcCtD
Procarbazine—Dizziness—Methotrexate—lymphatic system cancer	2.82e-05	0.000391	CcSEcCtD
Procarbazine—Vomiting—Methotrexate—lymphatic system cancer	2.71e-05	0.000376	CcSEcCtD
Procarbazine—Rash—Methotrexate—lymphatic system cancer	2.69e-05	0.000373	CcSEcCtD
Procarbazine—Dermatitis—Methotrexate—lymphatic system cancer	2.69e-05	0.000373	CcSEcCtD
Procarbazine—Headache—Methotrexate—lymphatic system cancer	2.67e-05	0.000371	CcSEcCtD
Procarbazine—Nausea—Methotrexate—lymphatic system cancer	2.54e-05	0.000351	CcSEcCtD
